FMI
IDXX icon

F/M Investments’s Idexx Laboratories IDXX Stock Holding History

F/M Investments’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Sell
25,898
-595
-2% -$334K 0.69% 29
2026
Q1 		$14.9M Sell
26,493
-53
-0.2% -$34K 0.99% 23
2025
Q4 		$18M Sell
26,546
-669
-2% -$456K 0.68% 25
2025
Q3 		$17.4M Sell
27,215
-96
-0.4% -$58.3K 0.67% 28
2025
Q2 		$14.6M Buy
27,311
+133
+0.5% +$63.6K 0.53% 33
2025
Q1 		$11.4M Buy
+27,178
New +$11.8M 0.45% 46

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

F/M Investments's IDXX Position: Q2 2026 in Review

F/M Investments reduced its Idexx Laboratories (IDXX) stake by 2.2% in Q2 2026, selling an estimated $334K and leaving 25,898 shares worth $13.6M. The position accounts for 0.69% of the portfolio, ranked #29.

F/M Investments first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $18M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • F/M Investments held 25,898 shares of Idexx Laboratories worth $13.6M as of Q2 2026.
  • F/M Investments sold 595 Idexx Laboratories shares in Q2 2026, an estimated $334K.
  • Idexx Laboratories made up 0.69% of F/M Investments's portfolio in Q2 2026, its #29 holding.
  • F/M Investments first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • F/M Investments's Idexx Laboratories position peaked at $18M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.